Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 February 2021 | Story Supplied | Photo Supplied
Dr João Vidal is a research fellow at the Department of Plant Sciences and the Afromontane Research Unit (ARU) at the University of the Free State (UFS).

According to United Nations data projections for 2100, sub-Saharan Africa is set to experience a demographic explosion. The most rapid population growth zones in Africa are in or around mountains and the importance of managing these mountain ecosystems sustainably in order to maintain the benefits to such a growing population is critical, says Dr João Vidal, a research fellow at the Department of Plant Sciences and the Afromontane Research Unit (ARU) at the University of the Free State (UFS). 

The link between human population growth and the demand for water will impact these mountain grasslands. All of Africa’s important rivers originate in mountainous areas. The sustainable management of African mountain landscapes is thus vital for the sustained provision of quality water in suitable quantities. “Water is already limited in some places. This year we are facing another drought in South Africa, and if it was not for the mountains, it could have been much worse. The long-term resilience of Southern Africa’s mountains and their ecosystem services should be an absolute priority for both research and conservation,” says Dr Vidal.

Human population growth has several implications

As a mountain ecologist, his recent research is centred on developing indicators for monitoring biodiversity change in Southern Africa’s mountains. This is a collaborative research project with the South African Environmental Observation Network (SAEON), Ezemvelo KZN Wildlife, and the University of Pretoria.

Human population growth, as predicted for Southern Africa, has several implications for natural-resource management and biodiversity conservation. “Southern Africa has one of the highest proportions of grassland-dominated mountains in the world, comparable only to Central Asia,” says Dr Vidal. 

In December, UN Secretary-General António Guterres said during the launch of the 2021 Global Humanitarian Overview: “Conflict, climate change and COVID-19 have created the greatest humanitarian challenge since the Second World War. The number of people at risk of starvation has doubled. Hundreds of millions of children are out of school. Levels of extreme poverty have risen for the first time in 22 years.”

According to Dr Vidal this new scenario significantly increases the pressure on mountain environments and their biota, since people will have to find alternative ways of feeding their families, their animals, while the economy struggles to recover globally.

Through his research, Dr Vidal – together with a growing community of practices for Southern Africa’s mountains – aims to understand the socio-ecological functioning of these montane grasslands in order to encourage a science-policy-action interface for their sustainable management in a changing world. 


Alternative ways for measuring environmental change in mountains

Since much global mountain research is focused on forest-dominated mountains, Dr Vidal and his collaborators are developing specific tools to track climate change in grassy mountains.
He explains: “When you look at the available tools for tracking climate change in mountains, you have a tree line for many mountains in the world. However, with the Southern African grassy mountains, it is impossible to use such a tool. We are working on alternative ways for measuring environmental change in our mountains.

“As it gets warmer, certain communities of grasses may retract towards higher elevations because they need a certain minimum temperature to survive. The problem seems to be that current climate change is occurring at a much faster rate than most species might be able to retract. This means that higher temperatures may lead to habitat losses for temperature-vulnerable groups.

“Climate change is also making mountains increasingly vulnerable to ecological invasion by non-native species. The severe temperatures in mountains are a good barrier for many problematic lowland species. But with warmer temperatures in the mountains, these barriers are being weakened, increasing the number of potentially invasive plants in our mountains. With higher temperatures there is potential for a large guild of invasive trees to overrun grassland mountains affecting waterflow into dams and rivers. Examples are pines, willows, gums, and wattles, to name a few.

“The presence of invasive trees, especially along rivers, has long-term negative impacts on the functioning of mountain catchments. These trees destabilise riverbanks, extract large amounts of water, and cause local extinction of endemic montane biodiversity. In drier environments such as grasslands, this exacerbates the fragile water productivity,” he adds.

Global policymakers to recognise the value of grassy mountains 

It is important to draw attention to the value of natural grassy mountain systems around the world and to how threatened they are. The world’s grassy mountains need to be better studied and better placed on the global stage. This will encourage policy makers to recognise these systems and implement appropriate measures to facilitate their sustainable management. 

For the first time in 20 years, the recent International Panel of Climate Change (IPCC) report to the United Nations included a chapter focusing solely on mountains. “Policymakers are finally realising how disproportionately important mountain environments are and how dramatically they are affected by climate change,” says Dr Vidal. 

However, African mountains are underrepresented in research literature; it is the only continent for which there is no data included in the IPCC report. There is an urgent need to represent African mountains – especially Southern Africa’s mountains – on the global stage when it comes to climate change,” states Dr Vidal.

Dr Vidal is conducting this study in partnership with Dr Ralph Clark, Director of the ARU on the UFS Qwaqwa Campus

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept